July 22, 2025

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Navigating a 17.36% Potential Upside in the CNS Market

Supernus Pharmaceuticals, Inc. (SUPN), a prominent player in the healthcare sector, operates within the niche of drug manufacturers specializing in both specialty and generic products. Based in Rockville, Maryland, Supernus..

Addus HomeCare Corporation (ADUS) Stock Analysis: 27% Upside Potential Amid Robust Revenue Growth

Addus HomeCare Corporation (NASDAQ: ADUS), a key player in the healthcare sector, stands out with its promising financial metrics and growth prospects. With a market capitalization of $1.98 billion, this..

Ligand Pharmaceuticals (LGND): Investor Outlook on a Biotech Leader with a 46% Revenue Growth Surge

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a key player in the biotechnology sector, stands out with its robust portfolio of biopharmaceutical assets. The company, headquartered in Jupiter, Florida, has carved a..

Amedisys Inc (AMED) Stock Analysis: Navigating Valuation Metrics and Growth Potential in the Healthcare Sector

Amedisys Inc. (NASDAQ: AMED), a prominent player in the healthcare sector, operates in the medical care facilities industry, specializing in providing crucial home health, hospice, and high acuity care services..

Astrana Health Inc. (ASTH) Stock Analysis: A 105% Upside Potential Amidst Robust Revenue Growth

Astrana Health Inc. (NASDAQ: ASTH), a healthcare management company headquartered in Alhambra, California, is emerging as a compelling investment opportunity within the medical care facilities industry. With a market capitalization..

Teladoc Health, Inc. (TDOC) Investor Outlook: Navigating the Virtual Healthcare Landscape with a 7.73% Potential Upside

Teladoc Health, Inc. (NYSE: TDOC) is a key player in the burgeoning virtual healthcare sector, offering a range of integrated care solutions and mental health services via its BetterHelp platform...

Perrigo Company plc (PRGO) Investor Outlook: Exploring a 35% Potential Upside in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO), a significant player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is commanding attention with a compelling potential upside of..

Ascentage Pharma Group (AAPG) Stock Analysis: Navigating High Growth in Biotechnology with Significant Challenges

Ascentage Pharma Group International (NASDAQ: AAPG), a prominent player in the biotechnology sector, is making waves with its ambitious pipeline targeting cancers, chronic hepatitis B, and age-related diseases. Headquartered in..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating a 3.36% Potential Upside Amidst Healthcare Sector Dynamics

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, operates senior living communities across the United States. With a market capitalization of $1.81 billion, the company..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: A Biotech with 182.60% Potential Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, has captured investor attention with its promising drug pipeline and significant upside potential. The company, based in San Diego, is focused..

PACS Group, Inc. (PACS) Stock Analysis: A 162% Upside Potential in Healthcare

PACS Group, Inc. (NASDAQ: PACS), a prominent player in the healthcare sector, is catching the eye of investors with a staggering potential upside of 162.48%. Operating in the medical care..

Indivior PLC (INDV) Stock Analysis: Exploring a 23.4% Upside Potential in the Healthcare Sector

Indivior PLC (INDV), a notable player in the healthcare sector, particularly within the drug manufacturers’ specialty and generic industry, presents an intriguing opportunity for investors seeking exposure to the opioid..

Merus N.V. (MRUS) Stock Analysis: Strong Buy Ratings and Promising 44% Upside Potential

Merus N.V. (NASDAQ: MRUS) is gaining attention in the biotechnology sector with its promising pipeline of bispecific antibody therapeutics. Based in the Netherlands, this clinical-stage immuno-oncology company is making significant..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: 48.55% Potential Upside Sparks Investor Interest

For investors seeking opportunities in the healthcare sector, Amneal Pharmaceuticals, Inc. (AMRX) presents a compelling case with a potential upside of 48.55%, according to recent analyst ratings. This global biopharmaceutical..

James Cropper sets cash-first plan as Advanced Materials targets growth (LON:CRPR)

CEO David Stirling and CFO Andrew Goody report FY to 29 March 2025: revenue just under £100m, EBITDA just under £7m, net debt down nearly £3m to below 2x EBITDA...

BGM Group Ltd. (BGM): Investor Outlook Amidst a Challenging Revenue Landscape in the Healthcare Sector

BGM Group Ltd. (BGM), a key player in the healthcare sector specializing in drug manufacturing, is navigating a complex market environment. With a market capitalization of $2.13 billion, this China-based..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Unveiling the 132% Upside Potential

Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical innovator, is making waves in the biotechnology sector with its ambitious focus on neurodegenerative and lysosomal storage diseases. Despite its current stock price..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Significant Upside Potential Amidst Innovative Genetic Medicines Development

Beam Therapeutics Inc. (NASDAQ: BEAM) is steadily carving out its niche in the biotechnology sector with its focus on precision genetic medicines. As the company continues to develop groundbreaking treatments..

Clover Health Investments (CLOV): Analyzing the 50% Upside Potential in the Healthcare Sector

Clover Health Investments, Corp (NASDAQ: CLOV) is steadily carving a niche in the healthcare sector, focusing primarily on Medicare Advantage plans in the United States. Based in Wilmington, Delaware, Clover..

Immunovant, Inc. (IMVT) Stock Analysis: Seizing a 145% Upside in the Biotech Sector

Immunovant, Inc. (NASDAQ: IMVT), a dynamic player in the biotechnology sector, has been making waves with its ambitious pursuits in the field of autoimmune therapies. As a clinical-stage immunology company,..

Search

Funds

July 22, 2025

James Cropper sets cash-first plan as Advanced Materials targets growth (LON:CRPR)

CEO David Stirling and CFO Andrew Goody report FY to 29 March 2025: revenue just under £100m, EBITDA just under £7m, net debt down nearly £3m to below 2x EBITDA...
Search

Funds

July 22, 2025

FTSE 100

Funds